Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of INV-9956 in adults with metastatic castration…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• INV-9956

Snippet

Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. | Conditions: Advanced Metastatic Castration Resistant Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING